Modulation of inflammatory cytokine secretion

Modulation of inflammatory cytokine secretion refers to the process by which the production and release of pro-inflammatory and anti-inflammatory signaling proteins—known as cytokines—are regulated within immune cells. Cytokines are critical mediators in the body’s immune response; they orchestrate cellular communication during inflammation by acting as chemical messengers that direct other cells on how to respond during infection or injury[4][5][6]. The process is highly regulated at multiple levels including gene transcription, translation, post-translational modification, intracellular trafficking through organelles like the endoplasmic reticulum and Golgi apparatus, vesicular transport involving SNARE proteins and Rab GTPases, and exocytosis at the cell membrane[1][2][3].\n\nKey innate immune cells involved include macrophages—which secrete a range of inflammatory mediators such as TNF-alpha, IL‑1β, IL‑6—and eosinophils. These cells can rapidly increase their output upon stimulation by pathogens or tissue damage signals. Dysregulation in this system can lead to excessive inflammation implicated in autoimmune diseases and chronic inflammatory conditions[4][5]. Therapeutic strategies often target either individual key cytokines with biologic drugs or broader regulatory mechanisms using small molecules.

Other names

Inflammatory cytokine release modulationCytokine secretion regulationCytokine release modulation

Inhibition or enhancement of cytokine synthesis and/or secretion pathways; Blockade of specific cytokines or their receptors (e.g., anti-TNF antibodies block TNF signaling); Modulation of intracellular signaling cascades involved in cytokine production and release